Christine K. Chiou
Investor Relations Contact at ZAI LAB LIMITED
Profile
Christine K.
Chiou is currently the Senior Vice President & Head-Investor Relations at Zai Lab Ltd.
Prior to her current position, she worked as the Head-Investor Relations at Incyte Corp.
from 2019 to 2023.
She also held the position of Principal at Merck & Co., Inc., Research Analyst at Daiichi Sankyo, Inc., and Investor Relations Contact at Allergan Ltd.
(Ireland).
Additionally, she worked as an Assistant Vice President & Equity Analyst at Barclays Capital, Inc. from 2011 to 2013.
Ms. Chiou obtained an MBA from The Trustees of Columbia University in The City of New York in 2009 and completed her undergraduate studies at Bryn Mawr College.
Christine K. Chiou active positions
| Companies | Position | Start |
|---|---|---|
| ZAI LAB LIMITED | Investor Relations Contact | 30/04/2023 |
Former positions of Christine K. Chiou
| Companies | Position | End |
|---|---|---|
| INCYTE CORPORATION | Investor Relations Contact | 30/04/2023 |
| ALLERGAN PLC | Investor Relations Contact | 30/09/2019 |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Analyst-Equity | 30/06/2013 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 29/11/2010 |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Training of Christine K. Chiou
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Bryn Mawr College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ZAI LAB LIMITED | Health Technology |
| Private companies | 4 |
|---|---|
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Christine K. Chiou
